OBJECTIVE: Both categorical and dimensional methods appear relevant to classifying psychotic disorders; however, there is no clear consensus on the most appropriate categories and dimensions or on the best approach for constructing nosologic criteria that integrate these 2 methods. This review examines the evidence on specific dimensions and categories that would best characterize psychoses. METHOD: Entries in the MEDLINE database between 1980 and 2011 were searched for studies of the dimensional and/or categorical structure of psychosis. Studies were included if samples represented a spectrum of psychotic disorders and dimensions/categories were empirically derived using principal components analysis, factor analysis, or latent class analysis. RESULTS: Most dimensional studies observed 4 or 5 dimensions within psychosis, with positive, negative, disorganization, and affective symptom domains most frequently reported. Substance abuse, anxiety, early onset/developmental, insight, cognition, hostility, and behavioral/social disturbance dimensions appeared in some studies. Categorical studies suggested 3 to 7 major classes within psychosis, including a class similar to Kraepelin's dementia praecox and one or more classes with significant mood components. Only 2 studies compared the relative fit of empirically derived dimensions and categories within the same data set, and each had significant limitations. CONCLUSION: There is relatively consistent evidence on appropriate categories and dimensions for characterizing psychoses. However, the lack of studies directly comparing or combining these approaches provides insufficient evidence for definitive conclusions about their relative merits and integration. The authors provide specific recommendations for designing future studies to identify valid dimensions and/or categories of the psychoses and investigate hybrid approaches to model the structure of the underlying illnesses.
OBJECTIVE: Both categorical and dimensional methods appear relevant to classifying psychotic disorders; however, there is no clear consensus on the most appropriate categories and dimensions or on the best approach for constructing nosologic criteria that integrate these 2 methods. This review examines the evidence on specific dimensions and categories that would best characterize psychoses. METHOD: Entries in the MEDLINE database between 1980 and 2011 were searched for studies of the dimensional and/or categorical structure of psychosis. Studies were included if samples represented a spectrum of psychotic disorders and dimensions/categories were empirically derived using principal components analysis, factor analysis, or latent class analysis. RESULTS: Most dimensional studies observed 4 or 5 dimensions within psychosis, with positive, negative, disorganization, and affective symptom domains most frequently reported. Substance abuse, anxiety, early onset/developmental, insight, cognition, hostility, and behavioral/social disturbance dimensions appeared in some studies. Categorical studies suggested 3 to 7 major classes within psychosis, including a class similar to Kraepelin's dementia praecox and one or more classes with significant mood components. Only 2 studies compared the relative fit of empirically derived dimensions and categories within the same data set, and each had significant limitations. CONCLUSION: There is relatively consistent evidence on appropriate categories and dimensions for characterizing psychoses. However, the lack of studies directly comparing or combining these approaches provides insufficient evidence for definitive conclusions about their relative merits and integration. The authors provide specific recommendations for designing future studies to identify valid dimensions and/or categories of the psychoses and investigate hybrid approaches to model the structure of the underlying illnesses.
Authors: H Wickham; C Walsh; P Asherson; C Taylor; T Sigmundson; M Gill; M J Owen; P McGuffin; R Murray; P Sham Journal: Schizophr Res Date: 2001-03-01 Impact factor: 4.939
Authors: A M McIntosh; A Forrester; S M Lawrie; M Byrne; A Harper; J N Kestelman; J J Best; E C Johnstone; D G Owens Journal: Psychol Med Date: 2001-01 Impact factor: 7.723
Authors: John A McGrath; Gerald Nestadt; Kung-Yee Liang; Virginia K Lasseter; Paula S Wolyniec; M Danielle Fallin; Mary H Thornquist; James R Luke; Ann E Pulver Journal: Schizophr Bull Date: 2004 Impact factor: 9.306
Authors: Kirsten E S Craddock; Xueping Zhou; Siyuan Liu; Peter Gochman; Dwight Dickinson; Judith L Rapoport Journal: Schizophr Res Date: 2017-11-13 Impact factor: 4.939
Authors: Joseph J Shenker; Sarojini M Sengupta; Ridha Joober; Ashok Malla; M Mallar Chakravarty; Martin Lepage Journal: J Psychiatry Neurosci Date: 2017-05 Impact factor: 6.186
Authors: Dan J Stein; Steven J Shoptaw; Daniel V Vigo; Crick Lund; Pim Cuijpers; Jason Bantjes; Norman Sartorius; Mario Maj Journal: World Psychiatry Date: 2022-10 Impact factor: 79.683
Authors: Anna Alkelai; Lior Greenbaum; Anna R Docherty; Andrey A Shabalin; Gundula Povysil; Ayan Malakar; Daniel Hughes; Shannon L Delaney; Emma P Peabody; James McNamara; Sahar Gelfman; Evan H Baugh; Anthony W Zoghbi; Matthew B Harms; Hann-Shyan Hwang; Anat Grossman-Jonish; Vimla Aggarwal; Erin L Heinzen; Vaidehi Jobanputra; Ann E Pulver; Bernard Lerer; David B Goldstein Journal: Mol Psychiatry Date: 2021-11-19 Impact factor: 13.437
Authors: Paris Alexandros Lalousis; Stephen J Wood; Lianne Schmaal; Katharine Chisholm; Sian Lowri Griffiths; Renate L E P Reniers; Alessandro Bertolino; Stefan Borgwardt; Paolo Brambilla; Joseph Kambeitz; Rebekka Lencer; Christos Pantelis; Stephan Ruhrmann; Raimo K R Salokangas; Frauke Schultze-Lutter; Carolina Bonivento; Dominic Dwyer; Adele Ferro; Theresa Haidl; Marlene Rosen; Andre Schmidt; Eva Meisenzahl; Nikolaos Koutsouleris; Rachel Upthegrove Journal: Schizophr Bull Date: 2021-07-08 Impact factor: 9.306